HempNewsAudio – Earth Science Tech, Inc. (ETST) at the Vanguard of the Cannabinoid Therapeutics Surge
Related Editorial Leveraging ever-expanding scientific evidence of the therapeutic efficacy of CBD (cannabidiol), specialty biotechnology companies are creating novel new formulations of the chemical compound to capitalize on the titanic growth expected in the cannabis-derived pharmaceutical and nutraceutical markets. Global medical marijuana market expected to exceed $55 billion by 2025 Global nutraceuticals market projected to surpass $319 billion by 2023 CBD pharmaceutical and nutraceutical companies poised to reap huge rewards Diverse CBD product lines provide competitive advantages Cannabinoids have been used for medicinal purposes for millennia, but it wasn’t until the discovery of the human endocannabinoid system in the 1990s…